7 diciembre 2014
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/LjQp_4A7tgQ/141207091428.htm
